Jan. 2 (Bloomberg) — IMS Health Holdings Inc., the health care focused information technology company taken private four years ago, filed for a $100 million initial public offering.

The figure is a placeholder used to calculate fees and may change. IMS, backed by Canada Pension Plan Investment Board, TPG Capital and Leonard Green & Partners LP, plans to use the funds for a proposed debt refinancing, according to today's regulatory filing. JPMorgan Chase & Co., Goldman Sachs Group Inc. and Morgan Stanley are managing the IPO.

IMS, which provides prescription data to drugmakers and analysts, posted $1.9 billion in revenue for the first nine months of 2013, with operating margins of 15 percent, according to the filing. The Danbury, Connecticut-based company was said to be considering an IPO as well as a sale process as of last month, possibly seeking a valuation of at least $8 billion, according to people familiar with the situation.

Recommended For You

IMS was acquired by the sponsors for about $5.2 billion including debt in 2010. Since early 2011, IMS has invested $587 million in 22 acquisitions of its own, including Appature Inc. and the consumer-health business of Nielsen Holdings NV, the filing shows.

The company plans to apply to list its shares on the New York Stock Exchange under the symbol IMS.

Copyright 2018 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.